Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

2.64
+0.240010.00%
Post-market: 2.650.0100+0.38%18:59 EDT
Volume:3.41M
Turnover:8.89M
Market Cap:415.92M
PE:5.44
High:2.71
Open:2.46
Low:2.43
Close:2.40
Loading ...
May 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 25, 2023

Major Issues Report

Form 8-K - Current report
Aug 24, 2023

Correspondence

Form CORRESP - Correspondence
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 03, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]